Mice heterozygous for CREB binding protein are hypersensitive to γ-radiation and invariably develop myelodysplastic/myeloproliferative neoplasm.

[1]  G. Zambetti,et al.  Double null cells reveal that CBP and p300 are dispensable for p53 targets p21 and Mdm2 but variably required for target genes of other signaling pathways , 2011, Cell cycle.

[2]  J. Sweasy,et al.  Variant base excision repair proteins: contributors to genomic instability. , 2010, Seminars in cancer biology.

[3]  W. Kraus,et al.  The PARP side of the nucleus: molecular actions, physiological outcomes, and clinical targets. , 2010, Molecular cell.

[4]  P. Rosenberg,et al.  Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study , 2010, British journal of haematology.

[5]  P. Aplan,et al.  Mouse models of myelodysplastic syndromes. , 2010, Hematology/oncology clinics of North America.

[6]  L. Kasper,et al.  Target gene context influences the transcriptional requirement for the KAT3 family of CBP and p300 histone acetyltransferases , 2010, Epigenetics.

[7]  C. Bloomfield,et al.  The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. , 2009, Blood.

[8]  R. Neuwirtová,et al.  Oxidative DNA damage in bone marrow cells of patients with low-risk myelodysplastic syndrome. , 2009, Leukemia research.

[9]  W. Vainchenker,et al.  JAK2 stimulates homologous recombination and genetic instability: potential implication in the heterogeneity of myeloproliferative disorders. , 2008, Blood.

[10]  R. Larson,et al.  Therapy-related myeloid leukemia. , 2008, Seminars in oncology.

[11]  Jinshui Fan,et al.  Internal tandem duplication of FLT3 (FLT3/ITD) induces increased ROS production, DNA damage, and misrepair: implications for poor prognosis in AML. , 2008, Blood.

[12]  A. Jankowska,et al.  Base excision repair dysfunction in a subgroup of patients with myelodysplastic syndrome , 2008, Leukemia.

[13]  Michael L. Creech,et al.  Integration of biological networks and gene expression data using Cytoscape , 2007, Nature Protocols.

[14]  A. El-Osta,et al.  Disparity of histone deacetylase inhibition on repair of radiation-induced DNA damage on euchromatin and constitutive heterochromatin compartments , 2007, Oncogene.

[15]  M. Minden,et al.  Myelodysplastic syndromes: the complexity of stem-cell diseases , 2007, Nature Reviews Cancer.

[16]  T. Skorski,et al.  BCR/ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance. , 2006, Blood.

[17]  S. L. Wong,et al.  Towards a proteome-scale map of the human protein–protein interaction network , 2005, Nature.

[18]  Martin Kuiper,et al.  BiNGO: a Cytoscape plugin to assess overrepresentation of Gene Ontology categories in Biological Networks , 2005, Bioinform..

[19]  David Hawke,et al.  A role for cell-cycle-regulated histone H3 lysine 56 acetylation in the DNA damage response , 2005, Nature.

[20]  Shridar Ganesan,et al.  Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing. , 2005, Genes & development.

[21]  T. Skorski,et al.  BCR/ABL oncogenic kinase promotes unfaithful repair of the reactive oxygen species-dependent DNA double-strand breaks. , 2004, Blood.

[22]  Jean YH Yang,et al.  Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.

[23]  Benjamin M. Bolstad,et al.  affy - analysis of Affymetrix GeneChip data at the probe level , 2004, Bioinform..

[24]  S. Ban,et al.  Chromosomal instability and radiosensitivity in myelodysplastic syndrome cells , 2002, Leukemia.

[25]  N. Harris,et al.  The World Health Organization (WHO) classification of the myeloid neoplasms. , 2002, Blood.

[26]  John T. Dimos,et al.  A Stem Cell Molecular Signature , 2002, Science.

[27]  David Baltimore,et al.  Germline Transmission and Tissue-Specific Expression of Transgenes Delivered by Lentiviral Vectors , 2002, Science.

[28]  P. Rubegni,et al.  Rothmund‐Thomson Syndrome (Thomson‐Type) and Myelodysplasia , 2001, Pediatric dermatology.

[29]  F. Speleman,et al.  Chromosomal aberrations in Bloom syndrome patients with myeloid malignancies. , 2001, Cancer genetics and cytogenetics.

[30]  A. Trainer,et al.  Rothmund–Thomson Syndrome with Myelodysplasia , 2001, Pediatric dermatology.

[31]  L. Loeb,et al.  A mutator phenotype in cancer. , 2001, Cancer research.

[32]  I. Weissman,et al.  A clonogenic common myeloid progenitor that gives rise to all myeloid lineages , 2000, Nature.

[33]  H. Ruffner,et al.  CBP/p300 interact with and function as transcriptional coactivators of BRCA1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[34]  D. Livingston,et al.  Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP. , 2000, Genes & development.

[35]  David Newsome,et al.  Gene Dosage–Dependent Embryonic Development and Proliferation Defects in Mice Lacking the Transcriptional Integrator p300 , 1998, Cell.

[36]  I. Weissman,et al.  Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow , 1997, Cell.

[37]  Wei Gu,et al.  Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain , 1997, Cell.

[38]  Wei Gu,et al.  Synergistic activation of transcription by CBP and p53 , 1997, Nature.

[39]  C. Glass,et al.  Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[40]  Hiromitsu Nakauchi,et al.  Long-Term Lymphohematopoietic Reconstitution by a Single CD34-Low/Negative Hematopoietic Stem Cell , 1996, Science.

[41]  Thorsten Heinzel,et al.  A CBP Integrator Complex Mediates Transcriptional Activation and AP-1 Inhibition by Nuclear Receptors , 1996, Cell.

[42]  B. Palsson,et al.  Consistent and high rates of gene transfer can be obtained using flow-through transduction over a wide range of retroviral titers. , 1996, Human gene therapy.

[43]  S. Collins,et al.  Lymphohematopoietic progenitors immortalized by a retroviral vector harboring a dominant-negative retinoic acid receptor can recapitulate lymphoid, myeloid, and erythroid development. , 1994, Genes & development.

[44]  H. Taguchi,et al.  Bloom's syndrome complicated by myelodysplastic syndrome and multiple neoplasia. , 1993, Internal medicine.

[45]  D. Harrington.  A class of rank test procedures for censored survival data , 1982 .

[46]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[47]  F. Naeim.  8 – Myelodysplastic Syndromes/Neoplasms—Overview , 2013 .

[48]  Kriston L. McGary,et al.  Open Access Method , 2007 .